HARBOURVEST PARTNERS LLC - OYSTER PT PHARMA INC ownership

OYSTER PT PHARMA INC's ticker is OYST and the CUSIP is 69242L106. A total of 54 filers reported holding OYSTER PT PHARMA INC in Q4 2022. The put-call ratio across all filers is 4.81 and the average weighting 0.5%.

Quarter-by-quarter ownership
HARBOURVEST PARTNERS LLC ownership history of OYSTER PT PHARMA INC
ValueSharesWeighting
Q3 2022$71,000
+31.5%
12,5600.0%0.02%
+27.8%
Q2 2022$54,000
-63.0%
12,5600.0%0.02%
-40.0%
Q1 2022$146,000
-36.2%
12,5600.0%0.03%
+3.4%
Q4 2021$229,000
+53.7%
12,5600.0%0.03%
+107.1%
Q3 2021$149,000
-44.2%
12,560
-19.2%
0.01%
-46.2%
Q2 2021$267,000
-57.3%
15,545
-54.5%
0.03%
-69.0%
Q1 2021$625,00034,1850.08%
Other shareholders
OYSTER PT PHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 2,768,586$32,226,00014.34%
Paradigm Biocapital Advisors LP 987,698$11,497,0003.04%
NEA Management Company, LLC 5,925,287$68,970,0001.99%
KPCB XIV Associates, LLC 367,987$4,283,0001.61%
Telemark Asset Management, LLC 787,026$9,161,0000.81%
COWEN AND COMPANY, LLC 509,794$5,934,0000.57%
RTW INVESTMENTS, LP 2,058,504$23,961,0000.50%
ACT CAPITAL MANAGEMENT, LLC 13,500$157,0000.17%
Kohlberg Kravis Roberts & Co. L.P. 1,039,622$12,101,0000.11%
Wildcat Capital Management, LLC 36,847$429,0000.11%
View complete list of OYSTER PT PHARMA INC shareholders